Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.
Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list.
Conundrum of treatment for early-stage hepatocellular carcinoma: radiofrequency ablation instead of liver transplantation as the first-line treatment?
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.
Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database.
Moving past "One size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantation.
Offer patterns of nationally placed livers by donation service area.
Center competition and outcomes following liver transplantation.
Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
